New Drugs in Select Gastrointestinal Disorders
Document Type
Conference Presentation
Organization
University of the Pacific
Location
virtual
Conference Dates
April 17-18 & April 24-25, 2021
Date of Presentation
4-17-2021
Abstract
Discuss broadly the clinical presentation and diagnostic criteria related to irritable bowel disease (IBS) and inflammatory bowel disease (IBD). Identify the new drugs which have been approved for IBS and IBD. Discuss the mechanism of action, adverse drug reactions, and monitoring parameters associated with each new drug. Discuss the clinical role and place in therapy of new drugs approved for IBS and IBD.
Recommended Citation
Vyas, Deepti, "New Drugs in Select Gastrointestinal Disorders" (2021). School of Pharmacy Faculty Presentations. 728.
https://scholarlycommons.pacific.edu/phs-facpres/728
